Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

124 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Metastatic melanoma.
Sun W, Schuchter LM. Sun W, et al. Among authors: schuchter lm. Curr Treat Options Oncol. 2001 Jun;2(3):193-202. doi: 10.1007/s11864-001-0033-5. Curr Treat Options Oncol. 2001. PMID: 12057119 Review.
Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma.
Flaherty KT, Lee SJ, Zhao F, Schuchter LM, Flaherty L, Kefford R, Atkins MB, Leming P, Kirkwood JM. Flaherty KT, et al. Among authors: schuchter lm. J Clin Oncol. 2013 Jan 20;31(3):373-9. doi: 10.1200/JCO.2012.42.1529. Epub 2012 Dec 17. J Clin Oncol. 2013. PMID: 23248256 Free PMC article. Clinical Trial.
Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM. Schuchter LM. J Clin Oncol. 2004 Jan 1;22(1):7-10. doi: 10.1200/JCO.2004.10.907. Epub 2003 Dec 9. J Clin Oncol. 2004. PMID: 14665612 No abstract available.
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.
Weber JS, Gibney G, Sullivan RJ, Sosman JA, Slingluff CL Jr, Lawrence DP, Logan TF, Schuchter LM, Nair S, Fecher L, Buchbinder EI, Berghorn E, Ruisi M, Kong G, Jiang J, Horak C, Hodi FS. Weber JS, et al. Among authors: schuchter lm. Lancet Oncol. 2016 Jul;17(7):943-955. doi: 10.1016/S1470-2045(16)30126-7. Epub 2016 Jun 4. Lancet Oncol. 2016. PMID: 27269740 Free PMC article. Clinical Trial.
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon.
Alpaugh RK, von Mehren M, Palazzo I, Atkins MB, Sparano JA, Schuchter L, Weiner LM, Dutcher JP. Alpaugh RK, et al. Among authors: schuchter l. Med Oncol. 1998 Sep;15(3):191-8. doi: 10.1007/BF02821938. Med Oncol. 1998. PMID: 9819796 Clinical Trial.
Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial.
Menzies AM, Ashworth MT, Swann S, Kefford RF, Flaherty K, Weber J, Infante JR, Kim KB, Gonzalez R, Hamid O, Schuchter L, Cebon J, Sosman JA, Little S, Sun P, Aktan G, Ouellet D, Jin F, Long GV, Daud A. Menzies AM, et al. Ann Oncol. 2015 Feb;26(2):415-21. doi: 10.1093/annonc/mdu529. Epub 2014 Nov 18. Ann Oncol. 2015. PMID: 25411413 Clinical Trial.
Early stage (I, II, III) melanoma.
Sondak VK, Ross MI, Schuchter LM. Sondak VK, et al. Among authors: schuchter lm. Curr Treat Options Oncol. 2001 Jun;2(3):183-91. doi: 10.1007/s11864-001-0032-6. Curr Treat Options Oncol. 2001. PMID: 12057118 Review.
Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy.
Einzig AI, Schuchter LM, Recio A, Coatsworth S, Rodriquez R, Wiernik PH. Einzig AI, et al. Among authors: schuchter lm. Med Oncol. 1996 Jun;13(2):111-7. doi: 10.1007/BF02993861. Med Oncol. 1996. PMID: 9013474 Clinical Trial.
Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.
Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM. Chapman PB, et al. Among authors: schuchter lm. J Clin Oncol. 1999 Sep;17(9):2745-51. doi: 10.1200/JCO.1999.17.9.2745. J Clin Oncol. 1999. PMID: 10561349 Clinical Trial.
Review of the 2001 AJCC staging system for cutaneous malignant melanoma.
Schuchter LM. Schuchter LM. Curr Oncol Rep. 2001 Jul;3(4):332-7. doi: 10.1007/s11912-001-0086-4. Curr Oncol Rep. 2001. PMID: 11389818 Review.
124 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page